News | Proton Therapy | February 01, 2019

University of Oklahoma Cancer Center Begins First Proton Therapy Treatments

Stephenson Cancer Center is one of three locations in the world with Mevion’s S250i system with Hyperscan pencil beam scanning technology

University of Oklahoma Cancer Center Begins First Proton Therapy Treatments

February 1, 2019 — Home to the largest and most comprehensive radiation therapy program in Oklahoma, the Stephenson Cancer Center at OU (The University of Oklahoma) Medicine has commenced proton therapy treatments with the Mevion S250i Proton Therapy System with Hyperscan Pencil Beam Scanning. Cleared by the U.S. Food and Drug Administration (FDA) in 2017, Hyperscan improves on existing scanning capabilities to deliver conformal fields of therapeutic radiation to tumors faster with more precision.

“We are excited to offer our patients this advanced radiation therapy,” said Terence Herman, M.D., radiation oncologist at the Stephenson Cancer Center. “We provide a full range of treatment options, which ensures patients can stay in Oklahoma to receive the best possible care. Proton therapy is yet another important tool we can use in the fight against cancer, and the Mevion Hyperscan system provides a level of precision that far exceeds that of earlier, non-focused proton treatment techniques.”

As part of OU Medicine’s National Cancer Institute-designated cancer center, the single-room compact proton system is embedded directly into the radiation oncology department. This efficient approach enables the cancer center to share existing resources and give patients access to OU Medicine’s robust collection of cancer-fighting therapies under one roof.

OU Medicine anticipates using the new system to treat brain tumors, select head-and-neck tumors, abdominal tumors such as pancreatic cancer, some rare neural tumors, localized prostate cancer and essentially all tumors in pediatric patients. Several research projects are planned as well.

For more information: www.mevion.com

Related Content

Arizona State University researchers (in collaboration with Banner MD Anderson Cancer Center) have discovered a biocompatible cost-effective hydrogel that can be used to monitor therapeutic doses of ionizing radiation by becoming more pink with increasing radiation exposure

Arizona State University researchers (in collaboration with Banner MD Anderson Cancer Center) have discovered a biocompatible cost-effective hydrogel that can be used to monitor therapeutic doses of ionizing radiation by becoming more pink with increasing radiation exposure. This picture shows a circle of hydrogel that was irradiated on the left half, which is slightly pink; whereas the right half of the gel is not irradiated and remains colorless.

News | Radiation Therapy | February 18, 2020
February 18, 2020 — More than half of all cancer patients undergo radiation therapy and the dose is critical.
Varian announced it has received FDA 510(k) clearance for its Ethos therapy, an Adaptive Intelligence solution. Ethos therapy is an artificial intelligence (AI)-driven holistic solution that provides an opportunity to transform cancer care.
News | Image Guided Radiation Therapy (IGRT) | February 11, 2020
February 11, 2020 — Varian announced it has received FDA 510(k) c
The radiation therapy market is projected to grow in through 2026

Image courtesy of Accuray

News | Proton Therapy | February 10, 2020
February 10, 2020 — Amid technological advancement, and notable research and development activities, the global ...
Accuray TomoTherapy total body irradiation
News | Radiation Therapy | February 07, 2020
February 7, 2020 — Accuray Incorporated announced that two new studies demonstrate the benefits of the ...
The luminescent oxygen probe PtG4 is injected during the week of radiation treatment and localizes between the cells of the tumor as illustrated by microscopy

An oxygen map image recovered from a mouse undergoing radiation therapy. The luminescent oxygen probe PtG4 is injected during the week of radiation treatment and localizes between the cells of the tumor as illustrated by microscopy (red). Image courtesy of Brian Pogue, PhD

News | Radiation Therapy | February 03, 2020
February 3, 2020 — Oxygen in cancer tumors is known to be a major factor that helps radiation therapy be successful.
IBA ProteusOne proton therapy system
News | Proton Therapy | January 29, 2020
January 29, 2020 — IBA (Ion Beam Applications S.A.) announced that it has signed a contract and received a major down
Six of the top 20 radiotherapy stories in 2019 involved proton therapy. This includes two video inetrviews shot during a site visit to the Northwestern Medicine Proton Center in the Chicago suburb of Warrenville, Ill.

Six of the top 20 radiotherapy stories in 2019 involved proton therapy. This includes two video inetrviews shot during a site visit to the Northwestern Medicine Proton Center in the Chicago suburb of Warrenville, Ill.

Feature | Radiation Oncology | January 03, 2020 | Dave Fornell, Editor
January 3, 2020 — Here is the top 20 pieces of radiation oncology content on the Imaging Technology News (ITN) websit
Artificial intelligence was by far the hottest topic in both radiology and radiation oncology in 2019, and AI is the subject of 8 of the top 2019 ITN videos. This image is a prostate treatment plan created autonomously by an AI algorithm from RaySearch and is the subject of the No. 2 video on the list. Deep learning in radiology and radiation oncology.

Artificial intelligence was by far the hottest topic in both radiology and radiation oncology in 2019, and AI is the subject of 8 of the top 2019 ITN videos. This image is a prostate treatment plan created autonomously by a machine learning algorithm from RaySearch and is the subject of the No. 2 video on the list. 

Feature | December 30, 2019
Here are the top 20 best performing videos posted on the Imaging Technology News website (ITN) from the past year, ba